Title of article :
Effect of Intravenous Ketorolac on Postoperative Pain in Mandibular Fracture Surgery; A Randomized, Double-Blind, Placebo-Controlled Trial
Author/Authors :
Eftekharian، Hamid Reza نويسنده , , Ilkhani Pak، Homa نويسنده ,
Issue Information :
فصلنامه با شماره پیاپی سال 2017
Abstract :
Objective: To evaluate the effects of intravenous ketorolac on early postoperative pain in patients with mandibular
fractures, who underwent surgical repair.
Methods: This prospective, randomized, placebo-controlled clinical trial was conducted in Shahid Rajaei
Hospital, affiliated with Shiraz University of Medical Sciences during a 1-year period from 2015 to 2016. We
included a total number of 50 patients with traumatic mandibular fractures who underwent surgical repair.
Patients with obvious contraindications to ketorolac such as asthma, renal dysfunction, peptic ulceration,
bleeding disorders, cardiovascular disease, mental retardation, or allergy to ketorolac or NSAIDS, were excluded.
The patients were randomly assigned to receive intravenous ketorolac (30 mg) at the end of operation in post
anesthesia care unit immediately upon the onset of pain (n=25), or intravenous distilled water as placebo (n=25).
Postoperative monitoring included non-invasive arterial blood pressure, ECG, and peripheral oxygen saturation.
The postoperative pain was evaluated by a nurse using visual analog scale (VAS) (0–100 mm) pain score 4 hours
after surgery and was compared between the two study groups.
Results: Overall we included 50 patients (25 per group) in the current study. The baseline characteristics
including age, gender, weight, operation duration, anesthesia duration and type of surgical procedure were
comparable between two study groups. Those who received placebo had significantly higher requirements for
analgesic use compared to ketorolac group (72% vs. 28%; p=0.002). Ketorolac significantly reduced the pain
intensity 30-min after the operation (p<0.001). There were no significant side effects associated with ketorolac.
Conclusion: Intravenous single-dose ketorolac is a safe and effective analgesic agent for the short-term
management of mild to moderate acute postoperative pain in mandibular fracture surgery and can be used as an
alternative to opioids.
Keywords :
KETOROLAC , Mandibular fracture , Surgery , analgesic , Postoperative pain
Journal title :
Bulletin of Emergency and Trauma
Journal title :
Bulletin of Emergency and Trauma